InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Plasmocure™ - Mycoplasma Elimination Reagent | Apolipoprotein E promotes invasion in oral squamous cell carcinoma. | 2017 | Am J Pathol. | Jayakar S.K. et al. | DOI: 10.1016/j.ajpath.2017.06.016 |
Normocin® - Antimicrobial Reagent | Pathogen-Mediated Inhibition of Anorexia Promotes Host Survival and Transmiss... | 2017 | Cell. | Rao S. et al. | DOI: 10.1016/j.cell.2017.01.006 |
MSU Crystals | Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRI... | 2016 | J Immunol. | Primiano M.J. et al. | DOI: 10.4049/jimmunol.1600035 |
AddaVax™ | A simple fluorescence-based assay for quantification of the Toll-Like Recepto... | 2017 | Vaccine. | Pollet J. et al. | DOI: 10.1016/j.vaccine.2017.01.077 |
Human TLR3 Reporter HEK293 Cells (NF-κB) | Identification of TLR2/TLR6 signalling lactic acid bacteria for supporting im... | 2016 | Sci Rep. | Ren C. et al. | DOI: 10.1038/srep34561 |
ODN 2006 FITC | Alginate-coated chitosan nanogels differentially modulate class-A and class-B... | 2014 | Nanomedicine. | Démoulins T. et al. | 10(8):1739-49. |
pINFUSE-hIgG1-Fc | Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor va... | 2013 | PNAS | Gil M. et al. | DOI: 10.1073/pnas.1220580110 |
LPS-RS | Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6. | 2017 | Immunol Cell Biol. | Modhiran N. et al. | DOI: 10.1038/icb.2017.5 |
ODN 1826 VacciGrade™ | HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuv... | 2016 | PLoS One. | Apostólico Jde S. et al. | DOI: 10.1371/journal.pone.0145637 |
ODN 2006 (ODN 7909) | Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulati... | 2014 | Innate Immun. | Adjobimey T. et al. | DOI: 10.1177/1753425913479414 |
TLR2-HA | TAK1 contributes to the enhanced responsiveness of LTB4-treated neutrophils t... | 2012 | Int Immunol. | Gaudreault E. et al. | DOI: 10.1093/intimm/dxs074 |
Loxoribine | Defective lymphoid organogenesis underlies the immune deficiency caused by a ... | 2015 | J Exp Med. | Mooster J.L. et al. | DOI: 10.1084/jem.20140979 |
TLR3-DN | Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpressio... | 2013 | PNAS | Galli R. et al. | DOI: 10.1073/pnas.1304610110 |
Poly(A:U) | A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inf... | 2015 | Nat Med. | Coll R.C. et al. | DOI: 10.1038/nm.3806 |
LPS-EK (LPS from E. coli K12) | Analysis of single-cell cytokine secretion reveals a role for paracrine signa... | 2015 | Sci Signal. | Xue Q. et al. | DOI: 10.1126/scisignal.aaa2155 |
Poly(dA:dT) | Structural and Functional Analysis of DDX41: a bispecific immune receptor for... | 2016 | Sci Rep. | Omura H. et al. | DOI: 10.1038/srep34756 |
Pepinh-MYD | IL-1R and MyD88 signaling in CD4+ T cells promote Th17 immunity and atheroscl... | 2017 | Cardiovasc Res. | Engelbertsen D. et al. | DOI: 10.1093/cvr/cvx196 |
MPLA Synthetic | Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery... | 2017 | Biomaterials. | Liang R. et al. | DOI: 10.1111/j.1751-1097.1996.tb09646.x |
OVA protein | HIV Interferes with Mycobacterium tuberculosis Antigen Presentation in Human ... | 2016 | Am J Pathol. | Singh S.K. et al. | DOI: 10.1016/j.ajpath.2016.08.003 |
Anti-hTLR1 Neutralizing mAb | The Natural Product Phyllanthusmin C Enhances IFN-γ Production by Human NK Ce... | 2014 | J Immunol. | Deng Y. et al. | DOI: 10.4049/jimmunol.1302600 |